Results

Total Results: 892 records

Showing results for "defining".

  1. www.uspreventiveservicestaskforce.org/uspstf/current-processes-refining-evidence-based-recommendation-development-table-2
    June 01, 2007 - Evidence grid defining letter grades. Standardized language for recommendations.
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z3BVaJRtyu8drWSHWYT_Yf
    There is no single cutoff for defining increased risk for all women.
  3. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nonpregnant-adolescents-and-adults1/human-immunodeficiency-virus-hiv-infection-screening
    June 11, 2019 - counts greater than 500/mm 3 associated with lower risk of a composite outcome of mortality, AIDS-defining … Both trials evaluated a composite primary outcome consisting of mortality, AIDS-defining events, and … cancer, or non–AIDS-defining invasive bacterial disease after 2.5 years (5.3% vs 9.2%; RR, 0.57 [95% … Analysis of D:A:D data (n = 41,762) found longer exposure to ART associated with lower risk of AIDS-defining … but not nonnucleoside reverse transcriptase inhibitors,was associated with higher risk of non–AIDS-defining
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/q_zxLD9JZFGoSPCrEHNk2g
    June 11, 2019 - cell counts greater than 500/mm3 associated with lower risk of a composite outcome of mortality, AIDS-defining … 0.21-0.73) NR TEMPRANO ANRS Daniel et al,15 2015 All-cause mortality, progression to AIDS, AIDS-defining … cancer, or non–AIDS-defining invasive bacterial disease: RR, 0.57 (95% CI, 0.35-0.95) All-cause mortality … Both trials evaluated a composite pri- mary outcome consisting of mortality, AIDS-defining events, and … cancer, or non–AIDS-defining invasive bacterial disease after 2.5 years (5.3% vs 9.2%; RR, 0.57 [95%
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/WJE2r5v4CHc9dMZ4GT7dnT
    initiation of ART and other interventions effectively reduce the risk of clinical progression to AIDS, AIDS-defining
  6. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/statin-use-in-adults-preventive-medication
    November 05, 2020 - The USPSTF also added socioeconomic status as a factor defining subgroups of interest and added a contextual
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/dvcAbDQWejyK38oxF8qgka
    November 01, 2012 - initiation at CD4 counts less than 0.250 � 109 cells/L was associated with a higher risk for death or AIDS-defining … initiation at CD4 counts of 0.350 to 0.500 � 109 cells/L was associated with lower risk for death or AIDS-defining … New evidence indicates that ART reduces risk for AIDS-defining events and death in persons with less … Results were also mixed for the combined outcome of death plus AIDS-defining events (not reported in … initiation at CD4 counts greater than 0.500 � 109 cells/L was associated with a lower risk for AIDS-defining
  8. www.uspreventiveservicestaskforce.org/uspstf/document/screening-for-hiv-in-adolescents-and-adults-evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2013
    November 20, 2012 - initiation at CD4 counts of 0.350 to 0.500 x 10 9 cells/L was associated with lower risk for death or AIDS-defining … New evidence indicates that ART reduces risk for AIDS-defining events and death in persons with less … Results were also mixed for the combined outcome of death plus AIDS-defining events (not reported in … initiation at CD4 counts greater than 0.500 x 10 9 cells/L was associated with a lower risk for AIDS-defining … When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-screening
    May 06, 2021 - The USPSTF also clarified the proposed approach for including interval cancers and for defining advanced
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan95/syphilis-infection-in-nonpregnant-adults-and-adolescents-june-2016
    September 18, 2014 - These clarifications include further defining persons who are eligible for screening (i.e., asymptomatic
  11. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vision-screening-children-ages-6-months-5-years
    July 24, 2025 - IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies
  12. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan36/carotid-artery-stenosis-screening-december-2007
    January 23, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Carotid Artery Stenosis: Screening, December 2007 January 23, 2014 Recommendations made by the USPSTF are independent of the U.S. government. T…
  13. www.uspreventiveservicestaskforce.org/uspstf/document/ResearchPlanFinal/carotid-artery-stenosis-screening-december-2007
    January 23, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Carotid Artery Stenosis: Screening, December 2007 January 23, 2014 Recommendations made by the USPSTF are independent of the U.S. government. T…
  14. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/early-food-allergen-introduction-infants-counseling
    September 05, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Early Allergen Introduction to Prevent Food Allergies in Infants: Counseling September 05, 2024 Recommendations made by the USPSTF are indepen…
  15. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/early-food-allergen-introduction-infants-counseling
    May 09, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Early Allergen Introduction to Prevent Food Allergies in Infants: Counseling May 09, 2024 Recommendations made by the USPSTF are indepen…
  16. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    May 14, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication May 14, 2020 Recommendations made by the USPSTF are independent of the U.S. governm…
  17. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
    September 26, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication September 26, 2019 Recommendations made by the USPSTF are ind…
  18. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/lipid-disorders-in-children-screening
    August 19, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Lipid Disorders in Children and Adolescents: Screening August 19, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They sh…
  19. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-b-virus-infection-screening
    March 14, 2019 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Hepatitis B Virus Infection in Adolescents and Adults: Screening March 14, 2019 Recommendations made by the USPSTF are independent of the U.S. governmen…
  20. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan142/obstructive-sleep-apnea-in-adults-screening-january-2017
    October 30, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Obstructive Sleep Apnea in Adults: Screening October 30, 2014 Recommendations made by the USPSTF are independent of the U.S. government. They sho…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: